A Patented
Platform Technology
N-Light™ rapid tests are powered by the ultra-sensitive AquaSpark™ platform technology and pioneering phage science.
Highly superior platform technology
NEMIS is proud to present AquaSpark™, an innovative platform technology that transforms the detection of live bacteria through chemiluminescence. This technology is based on synthetic molecules specifically engineered to emit light when interacting with bacterial enzymes. Our exclusive global rights, secured through a licensing agreement with Ramot at Tel Aviv University, include three pending patents that set us apart in the field of microbiology.
Chemiluminescent Probes for Diagnostics and in vivo Imaging
Chemiluminescent Probes for Protease Detection
Dioxetane Compounds for Microorganism Detection
The chemiluminescent light produced by AquaSpark™ is 1000 times brighter than traditional molecules. Consequently, this makes our N-Light™ solution a cutting-edge technology for sensitive detection across a wide range of applications. Due to the virtually endless possibilities of the AquaSpark™ modular toolbox, the N-Light™ platform can be tailored to detect any chosen microorganism, such as bacteria, parasites, viruses, or fungi.
Pioneering phage technology
NEMIS has developed unique bacteria-specific enrichment broths containing cocktails of bacteriophages to selectively eliminate competing microflora. NEMIS evaluated and uses 16 individual phages to selectively suppress competing microflora and false-positive bacteria, allowing precise detection of target bacteria without interference. This makes our tests more accurate and specific than rapid tests from competitors. In other words, this unique enrichment broth enhances the growth of targeted pathogens in a single enrichment step. As a result, NEMIS was able to achieve increased specificity and sensitivity of N-Light™ rapid tests.
In addition to leveraging phages for selectivity, NEMIS, in collaboration with ETH, developed an innovative genetically modified reporter phage designed to work with AquaSpark™ for rapid and precise pathogen detection.
Talk to expert about your current sampling method
Contact us
Specialized Assay Tablets
NEMIS has created specialized formulations of small assay tablets (3 mm in diameter) that effectively protect AquaSpark™ from environmental factors, significantly increasing the shelf life of the tests. These N-Light™ tablets also contain precise amounts of lysis agents where needed and disintegrate in under 10 seconds—compared to over 10 minutes for conventional tablets—delivering a superior user experience and enhancing assay efficiency.
AquaSpark™ lyophilisates and tablets undergo a comprehensive quality control (QC) testing process at NEMIS. This includes physical properties and verifying the uniform distribution of active ingredients within each batch. We utilize advanced technologies, such as ultra-high-performance liquid chromatography (UHPLC), to accurately detect the minute quantities of AquaSpark™ and other active ingredients in individual tablets (less than 0.05 milligrams).
Innovative N-Light™
Experience unmatched security and ease-of-use with the N-Light™ Biosafety Cap, designed for maximum safety and efficiency. The cap features a unique dual-position locking system that provides a secure, leak-proof seal in both initial and final settings.
1st position
The cap’s first position allows for multiple openings and closings with an intuitive twist and a reassuring snap, ensuring a robust seal under pressure up to 0.60 bar.
The cap’s first position allows for multiple openings and closings with an intuitive twist and a reassuring snap, ensuring a robust seal under pressure up to 0.60 bar.
2nd position
The second position permanently locks with a clear click, sealing the tube up to 0.95 bar and activating the N-Light™ tablet without compromising the seal.
The second position permanently locks with a clear click, sealing the tube up to 0.95 bar and activating the N-Light™ tablet without compromising the seal.
The N-Light™ Biosafety Cap is engineered to prevent accidental openings and leaks, adhering to the stringent UN3373 standards for the transport of biological materials.
Rapid Assay Development and Customer Engagement
We operate a cutting-edge biosafety lab for R&D in Au, Switzerland, where we excel in quickly developing robust assay formats.
Our ongoing field studies and pilot trials with clients help refine our offerings and provide tailored solutions, particularly in food safety environments.
Check our field studies
Dedicated Customer Support
Our expertise in microbial food safety is unmatched, enabling us to promptly address and resolve customer inquiries. This responsiveness not only enhances our brand but also drives customer satisfaction and loyalty, reinforcing NEMIS’s position as a leader in the microbial detection industry.
Talk to an Expert About Your Sampling needs
Book a demo